**McCullough, L.B., J. Coverdale, T. Bayer, et al. “Ethically Justified Guidelines for Family Planning Interventions to Prevent Pregnancy in Female Patients with Chronic Mental Illness.”
Minkoff, K., and R.E. Drake, eds.
Monahan, J., A.D. Redlich, J. Swanson, et al. “Use of Leverage to Improve Adherence to Psychiatric Treatment in the Community.”
Petrakis, I.L., C. Nich, and E. Ralevski. “Psychotic Spectrum Disorders and Alcohol Abuse: A Review of Pharmacotherapeutic Strategies and a Report on the Effectiveness of Naltrexone and Disulfiram.”
Roy, L., A.G. Crocker, T.L. Nicholls, et al. “Criminal Behavior and Victimization Among Homeless Individuals With Severe Mental Illness: A Systematic Review.”
Swanson, J.W., M.S. Swartz, R. Borum, et al. “Involuntary Out-Patient Commitment and Reduction of Violent Behaviour in Persons with Severe Mental Illness.”
Torrey, E.F.
Torrey, E.F., and M. Zdanowicz. “Outpatient Commitment: What, Why, and for Whom?”
Torrey, E.F., J. Stieber, J. Ezekiel, et al.
Torrey, E.F., M.T. Zdanowicz, A.D. Kennard, et al. “The Treatment of Persons with Mental Illness in Prisons and Jails: A State Survey.” Treatment Advocacy Center (2014). http://www.treatmentadvocacycenter.org/storage/documents/treatment-behind-bars/treatment-behind-bars.pdf
Velligan, D.I., M. Sajatovic, A. Hatch, A. et al. “Why do Psychiatric Patients Stop Antipsychotic Medication? A Systematic Review of Reasons for Nonadherence to Medication in Patients with Serious Mental Illness.”
Цитируемые источники
Anonymous, “Admissions to Hospitals for the Insane,” American Journal of Insanity 25 (1868): 74.
F. Dickerson, J. Schroeder, E. Katsafanas, et al., “Cigarette Smoking by Patients with Serious Mental Illness, 1999–2016: An Increasing Disparity,” Psychiatric Services 69 (2018): 147–53.
C. Cather, G.N. Pachas, K.M. Cieslak, et al., “Achieving Smoking Cessation in Individuals with Schizophrenia,” CNS Drugs 31 (2017): 471–81.
F. Dickerson, M.B. Adamos, E. Katsafanas et al., “The Association Among Smoking, HSV-1 Exposure, and Cognitive Functioning in Schizophrenia, Bipolar Disorder, and Non- Psychiatric Controls,” Schizophrenia Research 176 (2016): 566–71.
J. I. Benson and J.J. David, “Coffee Eating in Chronic Schizophrenic Patients,” American Journal of Psychiatry 143 (1986): 940–41.
P. B. Lucas, D. Pickar, J. Kelsoe, et al., “Effects of the Acute Administration of Caffeine in Patients with Schizophrenia,” Biological Psychiatry 28 (1990): 35–40.
S. R. Hirsch, “Precipitation of Antipsychotic Drugs in Interaction with Coffee or Tea,” letter, Lancet 2 (1979): 1130–31.
M. O. Zaslove, R.L. Russell, and E. Ross, “Effect of Caffeine Intake on Psychotic In-Patients,” British Journal of Psychiatry 159 (1991): 565–67.
F. Kulhanek, O.K. Linde, and G. Meisenberg, “Precipitation of Antipsychotic Drugs in Interaction with Coffee or Tea,” letter, Lancet 2 (1979): 1130.
J. A. Cabarillo, A.G. Herraiz, S.I. Ramos, et al., “Effects of Caffeine Withdrawal from the Diet on the Metabolism of Clozapine in Schizophrenic Patients,” Journal of Clinical Psychopharmacology 18 (1998): 311–16.
D. A. Regier, M.E. Farmer, D.S. Rae, et al., “Comorbidity of Mental Disorders with Alcohol and Other Drug Abuse,” Journal of American Medical Association 264 (1990): 2511–18.
Substance Abuse and Mental Health Services Administration, Results from the 2002 National Survey on Drug Use and Health: Detailed Tables (U.S. Department of Health and Human Services, 2003).
C. A. Pristach and C.M. Smith, “Self-Reported Effects of Alcohol Use on Symptoms of Schizophrenia,” Psychiatric Services 47 (1996): 421–23.
R. E. Drake and M.A. Wallach, “Substance Abuse among the Chronically Ill,” Hospital and Community Psychiatry 40 (1989): 1041–46.
M. S. Swartz, J.W. Swanson, and M.J. Hannon, “Detection of Illicit Substance Use among Persons with Schizophrenia by Radioimmunoassay of Hair,” Psychiatric Services 54 (2003): 891–95.